
Aileron Therapeutics, Inc. - Common Stock
Acción · US00887A2042 · ALRN (XNAS)
2,00 USD
06.06.2025 19:52
Cotizaciones actuales de Aileron Therapeutics, Inc. - Common Stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() NASDAQ |
RNTX
|
USD
|
06.06.2025 19:52
|
2,00 USD
| 1,97 USD
+1,78 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 2,56 % | 15,64 % | -5,21 % | -8,26 % | -39,21 % | -91,60 % |
Company Profile for Aileron Therapeutics, Inc. - Common Stock Share
Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. It has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.
Company Data
Name Aileron Therapeutics, Inc. - Common Stock
Company Aileron Therapeutics, Inc.
Symbol ALRN
Website
https://www.aileronrx.com
Primary Exchange
NASDAQ

ISIN US00887A2042
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. James Brian Windsor Ph.D.
Market Capitalization 46 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 285 Summer Street, 02210 Boston
IPO Date 2017-06-29
Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
13.01.2025 | ALRN | RNTX |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | ALRN |
NASDAQ | RNTX |
Weitere Aktien
Investoren die Aileron Therapeutics, Inc. - Common Stock die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.